Bionano Genomics (BNGO): Orin Hirschman now owns 9.9% of BNGO as a passive investor 9.9%
Orin Hirschman now owns 9.9% of BNGO as a passive investor.
- 9.9%
- Stake
- 1.17M
- Shares owned
- Stake as of
- Sep 30, 2026
- Filed
- Oct 19, 2026
Context
Written by software from the filings listed below · Oct 20, 2026
- What was filed. Orin Hirschman filed a SCHEDULE 13G on Oct 19, 2026 reporting 1,165,000 shares, 9.9% of the class of Bionano Genomics (BNGO). SEC Schedule 13G
4 more points, with the facts they come from, are in OQRO Pro.
Sign up freeThe story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
What came next
How to read SEC Schedule 13G
A Schedule 13D and a Schedule 13G both disclose beneficial ownership of more than 5% of a US company's voting shares. A 13D is the long form, filed by holders who may seek to influence or control the company, and it must state what they intend to do. A 13G is the short form, open only to passive holders and to certain institutions holding in the ordinary course of business, and it asks no question about intent.
Full guide: Schedule 13D vs Schedule 13G: what is the difference?
What else is on file for Bionano Genomics
For Bionano Genomics, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BNGO page.
How this filing works
Explore the data
Other disclosures at Bionano Genomics
Everything OQRO holds on this company is on its BNGO page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data